Barclays raised the firm’s price target on Veeva to $240 from $220 and keeps an Overweight rating on the shares ahead of the earnings report on February 29. The analyst is modeling 12% billings growth for Q4 and notes some large deals slipped to fiscal 2025, which the firm thinks “offers some de-risking.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VEEV: